PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 8–8 | Cite as

Assessing cost effectiveness of pneumococcal conjugate vaccines

Meeting report


  1. Sauboin C, et al. Comparing the Estimated Public Health Impact and Cost-Effectiveness of Phid-Cv and Pcv-13 in the Routine Immunisation Programme in Gavi-Eligible Countries (Sub-Saharan Africa and Asia/Oceania): a Modelling Study. 21st Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PIN34, 10 Nov 2018. Available from: URL:

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations